Blog

Jun
15
2015

Study Explores Possible Links between Diet/Exercise and Muscle Loss

3fab640a-adff-4390-ba24-004802f6da68 Researchers at the University of Southampton carried out a comprehensive review of the combined diet and exercise training trials of women and men ages 65 and over. Their goal? To learn more about how diet and exercise could prevent muscle loss. Their... Read more »

Jun
9
2015

Newly Discovered Small-Molecule Drug Could ‘Perk Up’ Aging Muscle Tissue

The discovery of a small-molecule drug by experts at UC Berkeley may offer hope for interventions that would rejuvenate aging muscle tissue.  In tests, the drug “perked up” old stem cells in the muscles and brains of mice.  “We established that you... Read more »

May
5
2015

Study: Night Owls More Likely to Develop Sarcopenia

If you are a night owl, you might be more prone to developing sarcopenia. So says a new study in The Journal of Clinical Endocrinology & Metabolism. The study found that night owls are more likely to develop conditions such as diabetes, metabolic syndrome, and sarcopenia than their early-rising... Read more »

Apr
27
2015

AIM Holds Symposium on ICD-10 Code at ICFSR Conference

The Aging in Motion Coalition conducted a symposium at this month’s International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston, Mass., on its proposal to establish an ICD-10 code for diagnosing sarcopenia patients. This represented an exciting opportunity for AIM to update the international sarcopenia research community on... Read more »

Dec
5
2014

AIM Comments on FDA’s Patient-Focused Drug Development Initiative

The AIM Coalition has provided a response to the Food and Drug Administration's (FDA) request for comments about its patient-focused drug development initiative.  In its response, AIM thanked the FDA and the Center for Drug Evaluation and Research for including sarcopenia as one of the diseases being considered for... Read more »